Akebia Therapeutics | AKBA - Прибыль до налогообложения





Прибыль до налогообложения Изменить Дата
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Amgen USD 1.51B 2.41B 2025-12
Ardelyx USD -400K 467K 2025-12
Astellas Pharma JPY 48.02B 85.93B 2026-03
AstraZeneca USD 3.91B 1.28B 2026-03
Bayer EUR -3.37B 2.21B 2025-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Celltrion KRW 10.5B 4.1B 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Exelixis USD 267.69M 15M 2026-03
Fresenius Medical Care EUR 340M 168.46M 2026-03
GlaxoSmithKline GBP 2.14B 919M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
J&J USD 7.82B 2.86B 2026-03
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Medical Developments International AUD -149K 466K 2025-06
Moderna USD -799M 612M 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pharma Mar EUR 1.6M 38.6M 2026-03
Prothena USD -21.58M 15.33M 2025-12
PTC Therapeutics USD -2.46M 136.62M 2026-03
Qiagen NV USD 109.17M 25.56M 2025-12
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Sartorius EUR 157.8M 76.1M 2026-03
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03